Evidence map›Paper›PMID 38276274›Full record

ReviewLife (Basel, Switzerland)2024

Artificial Intelligence in Heart Failure: Friend or Foe?

Angeliki Bourazana, Andrew Xanthopoulos, Alexandros Briasoulis, Dimitrios Magouliotis, Kyriakos Spiliopoulos, Thanos Athanasiou, George Vassilopoulos, John Skoularigis, Filippos Triposkiadis

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Artificial intelligence in heart failure.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  4. Review
  5. Evidence-Based Medicine: Past, Present, Future.Journal of clinical medicine · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angeliki BourazanaDepartment of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Andrew XanthopoulosDepartment of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.ORCID 0000-0002-9439-3946
Alexandros BriasoulisDivision of Cardiovascular Medicine, Section of Heart Failure and Transplantation, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-5740-9670
Dimitrios MagouliotisDepartment of Cardiothoracic Surgery, University of Thessaly, 41110 Larissa, Greece.ORCID 0000-0001-5417-6392
Kyriakos SpiliopoulosDepartment of Cardiothoracic Surgery, University of Thessaly, 41110 Larissa, Greece.ORCID 0000-0003-4332-258X
Thanos AthanasiouDepartment of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.
George VassilopoulosDepartment of Hematology, University Hospital of Larissa, University of Thessaly Medical School, 41110 Larissa, Greece.
John SkoularigisDepartment of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.ORCID 0000-0001-7159-2478
Filippos TriposkiadisDepartment of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.ORCID 0000-0001-6433-4016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent times, there have been notable changes in cardiovascular medicine, propelled by the swift advancements in artificial intelligence (AI). The present work provides an overview of the current applications and challenges of AI in the field of heart failure. It emphasizes the "garbage in, garbage out" issue, where AI systems can produce inaccurate results with skewed data. The discussion covers issues in heart failure diagnostic algorithms, particularly discrepancies between existing models. Concerns about the reliance on the left ventricular ejection fraction (LVEF) for classification and treatment are highlighted, showcasing differences in current scientific perceptions. This review also delves into challenges in implementing AI, including variable considerations and biases in training data. It underscores the limitations of current AI models in real-world scenarios and the difficulty in interpreting their predictions, contributing to limited physician trust in AI-based models. The overarching suggestion is that AI can be a valuable tool in clinicians' hands for treating heart failure patients, as far as existing medical inaccuracies have been addressed before integrating AI into these frameworks.

Indexed as

artificial intelligenceethicalheart failurelimitationsmachine learning

Identifiers

PMID38276274
PMCPMC10817517

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.